|
[Web Backlinks] \ [Manufacturing]
Pharmaceutical
Submit Your Link
 Buy Tramadol Online | PR 
If your search to buy Tramadol online has lead you here, you have found the safest place to buy tramadol at the lowest price available online. Tramadol is used to relieve moderate to moderately severe pain. Tramadol works by decreasing the brain's perception and response to pain. Read our information about Tramadol to determine your particular needs. | http://findmedsquick.com
keywords: buy tramadol online, cheap tramadol online |
|  |
|
15 May 12 - Manufacturing Pharmaceutical News
Aoxing Pharmaceutical Company Announces Third Quarter Fiscal 2012 Financial ...
JERSEY CITY, NJ, May 15, 2012 (MARKETWIRE via COMTEX) -- Aoxing Pharmaceutical Company, Inc. (ASE:AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management ...
ProMetic Receives $4.2 Million Follow-on Order from Major Global ...
Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful ...
SCH grants approval to manufacture, import drugs
The Qatar's Supreme Council of Health (SCH) has granted approval to five companies to establish manufacturing units for producing medicines and pharmaceutical products locally. The council has also issued licences to five more local companies to import ...
Biostar Pharmaceuticals, Inc. Announces 2012 First Quarter Financial Results
XIANYANG, China, May 15, 2012 /PRNewswire via COMTEX/ -- Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases ...
Akela Pharma reports financial results for the three months ended March 31, 2012
AUSTIN, TX, May 15, 2012 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), an industry leader in providing pharmaceutical contract dosage development and clinical and commercial manufacturing, today announced its financial results for the three ...
USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics
REDWOOD CITY, Calif., May 15, 2012 (BUSINESS WIRE) -- Codexis, Inc. (NASDAQ:CDXS) , a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States ...
Industry wants govt to adopt evidence based balanced pricing policy
Most importantly industry wants the government to take the cost of manufacturing as an important factor for formulation pricing as it will help to ensure reasonable prices.
Julphar breaks ground on $32m Algerian facility
The Gulf Pharmaceutical Industries, Julphar, has broken ground on its $32m manufacturing plant in Algeria. The new plant, to be known as Albrat, is being built in partnership with the Algerian Ministry of Health.
TPI Reports Third Quarter Fiscal Year 2012 Financial Results
TPI targets 80% production capacity by the end of June 2012. TPI will utilize about 40% of the Azithromycin raw material manufactured from JCM. TMT is established to distribute products manufactured by both TPI and other pharmaceutical companies to ...
Industrial Wireless: Improving the Flexibility of Pharmaceutical Plants
Around the world, pharmaceutical manufacturing is evolving from a high margin, large volume, make-to-stock, supply-driven operation to a price sensitive, small volume, make-to-order, value-driven operation.
China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
As of March 31, 2012, China Pharma had various pipeline drugs in different stages of active development. Some of these are highlighted below: The Company originally submitted application for production approval of Candesartan, a front-line drug therapy ...
Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution ...
Developed by Debiopharm, the products PamorelinŽ LA and SalvacylŽ are manufactured by Debio RP in Martigny, Debiopharm's site for applied research, controlled release formulation development and production. "We are very happy that Vifor Pharma and ...
Bristol-Myers unveils $20m expansion plan
During the past five years, at a cost of $48 million, the company established R&D cooperation arrangements with local counterparts, such as Wuxi AppTec Co and Simcere Pharmaceutical Co. "Manufacturing capacity expansion on the one hand reflects demand ...
Minitab Statistics for Pharmaceuticals and Medical Devices Training Coming to ...
Minitab Inc., the leading provider of software for quality improvement, will offer training on statistics for pharmaceuticals and medical devices in the San Jose, Costa Rica area June 11-13. As the pharmaceutical manufacturing industry wrestles with a ...
Patheon Transformation Continues With Adjustments To Its Global Platform
Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it continues to implement its corporate transformation strategy across its commercial and ...
Indian drug makers shake off dependence on China
Naresh Gupta, who heads Lupin Laboratories's bulk drug unit, also argues that the government should try to level the playing field for Indian manufacturers. Incidentally, Lupin is the only Indian pharma major that exports bulk drugs to China.
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical ...
Antares Pharma has two facilities in the US The Parenteral Products Group located in Minneapolis, Minnesota directs the development and manufacturing of the Company's reusable needle-free injection devices and related disposables, and develops its ...
Leading Specialty Pharmaceutical Company to Implement Ross Enterprise
ATLANTA, May 14, 2012 (BUSINESS WIRE) -- CDC Software, an enterprise software provider of on-premise and cloud technologies, today announced that Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, plans to implement Ross Enterprise ...
Stellar Pharmaceuticals Reports First Quarter 2012 Financial Results
This increase was largely driven by licensed domestic product net sales of $1906000 as a result of the acquisition and integration of Tribute Pharmaceuticals. International product sales also grew by 102% compared to the same period in 2011 to reach ...
Sunesis Pharmaceuticals Reports First Quarter 2012 Financial Results and ...
SOUTH SAN FRANCISCO, Calif., May 15, 2012 (GlobeNewswire via COMTEX) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today reported financial results for the quarter ended March 31, 2012.
|
